ABSTRACT
This study was undertaken to identify and evaluate the waste reduction management strategies in Glaxo Simithline (GSK) Nigeria Plc, Lagos. In generating total need to achieve the objective of the study, the researcher consulted many textbook, journals, periodicals and paper work. These were renewed and deductions and additions were made appropriately. The study was also conducted by using primary and secondary sources of data collection as well as percentage and made in the data analysis and interpretation. Based on the analysis of data some findings include that good waste reduction management strategies exist and these include but not limited to processes improvement strategies emphasis on efficiency maintenance of plants/equipment and employing qualified trained personnel. Therefore, this work suggest that the company should intensify, efforts towards achieving zero waste through establishment of secondary application for all waster generated.
TABLE OF CONTENTS
Title page ii
Approval page iii
Dedication iv
Acknowledgement v
Abstract x
Table of Contents xi
CHAPTER ONE
1.0 Introduction 1
1.1 Background of the study 1
1.2 Statement of the problem 6
1.3 Objective of the study 7
1.4 Research Question 8
1.5 Research Hypothesis 9
1.6 Significance of the Study 10
1.7 Scope of the Study 11
1.8 Limitation of the study 12
1.9 Definition of terms 13
References
CHAPTER TWO
2.1 Literature of Related Review 18
2.2 Waste Prevention Models 21
2.3 Waste Disposal Techniques 28
2.4 Waste minimization strategies 45
2.5 Case studies on Waste Minimization 50
2.6 Basel convention on Waste Management 52
2.7 Overview of facility- Glaxo smithline Nigeria Plc 53
2.8 Existing Waste Management strategies by (GSK) 53
References
CHAPTER THREE
Research Methodology
3.0 Introduction 58
3.1 Source of Data 59
3.2 Study Population 59
3.3 Sampling size Determination 60
3.4 Sampling Procedure 63
3.5 Data Collection Instrument 64
3.6 Method of Data Analysis 67
3.7 Decision Rule 70
3.8 Validity and Reliability of Instrument 71
References
CHAPTER FOUR
4.0 Data Presentation and Analysis 73
4.1 Presentation and Analysis of Data 73
4.2 Hypothesis Testing 78
4.3 Summary of Result 87
CHAPTER FIVE
Summary of Findings, Conclusion and Recommendation
5.1 Summary of Findings 88
5.2 Conclusion 90
5.3 Recommendation 93
Bibliography
Appendix
INTRODUCTION
Glaxo Smithkline (GSK) Nigeria Plc, is a corporate organization, which was incorporated in Nigeria as a public limited liability company in 1971. Currently it has tow factories located in Agbara and Ilupeju, GS is quoted on the Nigeria stock market and is positioned to be the leading pharmaceutical company in Nigeria GS line of product include
A. Analgesics; Panadol, Panadol Extra, Cotenol, Phensix and Phensicplus.
B. Nutritional drinks: Lucozads, lucozade boest etc
C. Multivitamin tonic: Extravite
D. Laxatives: Andrews liver salt.
E. Oral care: Macleans
The analgesics, multivitamin tonic and laxatives are manufactured at the Ilupeju factory, while the Agbara orsal care is under contract manufacture with UACP and PP as an embodiment of it’s valves GS integrates environment and safety into the very fabric of the business to benefit her various customers and to achieve:
- Compliance with all applicable laws, regulations legislation and GS environment and safety standards
- A work culture that promotes a safe work place characterized by absence of occupation injures and illnesses.
- Safe and environmentally responsible development and manufacture of her products.
- Protection of the environment through the optimal utilization of resources and prevention of any adverse impact on the environment and the global community.
- Worldwide leadership in the industry with a superior environment and safety vision: the foundation of a environment and safety programmes is set out in policy statement, which commits GS to
- Improve efficiency and reduce waste
- Maximize the efficient use of energy.
- Design packaging to minimize resources uses and maximize recycling capabilities.
- Operate responsibility and cooperatively with the community (Hagan, 2000).
There also, exist standards, covering emissions to air and water, waste disposal and energy usage in GSK Nigeria Plc generally, there exist following requirements:
- Identification and classification of waste
- Waste generation rates
- Segregation and storage of waste
- Identification and selection of waste recycling, recovery storage and disposal options
- Transportation of waste
- Waste disposal contractor management
- Documentation and record keeping
- Management of waste produced by contractors working for GSk
All manufacturing process are usually accomplained with by waste generation. In GSK sources of waste include the various raw and packaging materials, chemical and chemical products, intermediate and finished products, metal scraps, sand, spent grease oil, gaseous emissions/fumes petrochemical and domestic wastes.
These waste are commonly categorized into three forms viz solid waste, liquid/effluent waste, and sem-solid (paste form) waste.
These forms of waste could be hazardous or non-hazardous. The hazardous waste include:
a) Waste solvents – eg tablets/powers/liquid/or pastes destroyed by soaking and diluting with water, manufacturing floor washings, mopped up spill etc
- All waste laboratory chemicals-resulting from analysis expired chemical etc
- Use of asbestos and metals (equipment scrape/spare parts)
The non-hazardous waste include but not limited in packaging waste paper, plastic, food.
Waste management including strategies has been a global concern and its effect on environment is currently top on international agenda. To this effect GSK budget and spends an average of N2.5 million on waste management annually.
